List of insiders holdings for LABCORP HOLDINGS INC.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| KING DAVID P Director | 2020-05-07 12:05:56 | 312,554 19,542 | 332,096 | Form 4 |
| ELINGBURG WESLEY R EVP & Chief Financial Officer | 2005-05-06 15:57:46 | 143,744 0 | 143,744 | Form 4 |
| Schechter Adam H President & CEO | 2024-11-13 08:16:12 | 87,441 0 | 87,441 | Form 4 |
| Keller Deborah L CEO, Covance Drug Development | 2016-03-15 13:36:44 | 68,004 0 | 68,004 | Form 4 |
| Hayes William B Chief Financial Officer, EVP | 2014-06-10 16:24:18 | 66,767 0 | 66,767 | Form 4 |
| NOVAK RICHARD L EVP, Strategic Planning | 2006-03-08 11:02:22 | 62,270 0 | 62,270 | Form 4 |
| STARK STEVAN R Executive Vice President | 2004-03-17 16:23:38 | 49,730 0 | 49,730 | Form 4 |
| EISENBERG GLENN A Executive Vice President | 2024-12-04 09:59:45 | 36,866 0 | 36,866 | Form 4 |
| Ratliff John D CEO, Covance Drug Development | 2019-04-05 12:01:32 | 36,728 120 | 36,848 | Form 4 |
| Conrad Andrew J EVP, Chief Scientific Officer | 2011-02-11 17:13:09 | 26,541 6,100 | 32,641 | Form 4 |
| MAC MAHON THOMAS P Director | 2012-09-10 11:10:35 | 32,297 0 | 32,297 | Form 4 |
| Caveney Brian J EVP, Pres of ED, CMO & CSO | 2024-03-29 17:42:47 | 31,621 0 | 31,621 | Form 4 |
| EBERTS F SAMUEL III Chief Legal Officer, Secretary | 2019-02-14 16:10:35 | 29,587 0 | 29,587 | Form 4 |
| LAI GOLDMAN MYLA EVP & Chief Medical Officer | 2008-11-24 14:24:35 | 21,991 3,000 | 24,991 | Form 4 |
| Boyle James T. Jr. EVP,CEO of LabCorp Diagnostics | 2016-04-01 13:11:15 | 23,454 0 | 23,454 | Form 4 |
| Walton Andrew Scott EVP | 2012-04-11 14:57:30 | 22,298 0 | 22,298 | Form 4 |
| HARDISON DON M EVP | 2010-01-15 20:09:08 | 19,928 0 | 19,928 | Form 4 |
| Miller Benjamin R EVP, Sales & Marketing | 2008-03-28 11:02:48 | 19,927 0 | 19,927 | Form 4 |
| LANE WENDY E Director | 2014-05-12 17:03:23 | 18,988 400 | 19,388 | Form 4 |
| BELINGARD JEAN-LUC Director | 2024-02-08 12:43:22 | 19,200 0 | 19,200 | Form 4 |
| HAAS WILLIAM EVP, Esoterix Business | 2008-05-09 16:36:43 | 17,000 0 | 17,000 | Form 4 |
| Pike Thomas Pres & CEO Clinical Business | 2023-01-11 13:42:40 | 16,960 0 | 16,960 | Form 4 |
| SMITH BRADFORD T Director | 2009-02-24 15:22:25 | 16,030 0 | 16,030 | Form 4 |
| BERBERIAN LANCE EVP, CIO & CTO | 2024-08-07 08:47:07 | 15,921 0 | 15,921 | Form 4 |
| MITTELSTAEDT ROBERT E JR Director | 2019-05-13 12:12:32 | 15,515 0 | 15,515 | Form 4 |
| NEUPERT PETER M Director | 2024-02-08 12:49:13 | 14,778 0 | 14,778 | Form 4 |
| Kong Garheng Director | 2024-02-08 12:47:57 | 14,733 0 | 14,733 | Form 4 |
| ANDERSON KERRII B Director | 2024-10-25 09:26:23 | 13,722 288 | 14,010 | Form 4 |
| WEIKEL M KEITH Director | 2014-05-09 15:35:44 | 13,958 0 | 13,958 | Form 4 |
| Dodson Edward T Principal Accounting Officer | 2019-04-03 17:24:52 | 13,663 0 | 13,663 | Form 4 |
| POWELL JAMES B Director | 2004-05-05 16:23:47 | 13,060 0 | 13,060 | Form 4 |
| Kirchgraber Paul R CEO, Covance Drug Development | 2023-05-23 08:06:26 | 12,946 0 | 12,946 | Form 4 |
| Gary M. Huff CEO, LabCorp Diagnostics | 2018-09-06 10:21:42 | 12,918 0 | 12,918 | Form 4 |
| Troub Allen W EVP, Western Operations | 2007-03-05 17:39:35 | 12,697 0 | 12,697 | Form 4 |
| Cook Woodrow L EVP, Eastern Operations | 2007-11-01 16:20:16 | 12,535 0 | 12,535 | Form 4 |
| Rubenstein Arthur H Director | 2014-05-12 17:10:23 | 11,772 0 | 11,772 | Form 4 |
| WALLACE ANDREW G Director | 2007-05-03 14:17:02 | 11,654 0 | 11,654 | Form 4 |
| Parham Richelle P Director | 2024-02-08 12:50:14 | 11,369 0 | 11,369 | Form 4 |
| Wang Julia Aijun Chief Financial Officer, EVP | 2024-12-04 10:05:22 | 10,780 0 | 10,780 | Form 4 |
| HERRING JOSEPH L CEO of Covance Drug Division | 2015-08-04 14:15:13 | 10,404 0 | 10,404 | Form 4 |
| Williams R Sanders Director | 2024-02-08 12:52:23 | 9,539 0 | 9,539 | Form 4 |
| Brecher Mark E CMO, LabCorp Diagnostics | 2015-04-01 20:35:17 | 9,311 0 | 9,311 | Form 4 |
| Fonseca Lidia Chief Information Officer | 2013-04-01 15:45:38 | 9,087 0 | 9,087 | Form 4 |
| Gilliland Dwight Gary Director | 2024-12-04 09:55:40 | 7,712 0 | 7,712 | Form 4 |
| DiVincenzo Jonathan P. EVP, Pres, Central Labs & Intl | 2024-03-29 17:15:41 | 7,426 0 | 7,426 | Form 4 |
| GRAHAM ANITA Z EVP, CHRO | 2024-02-08 15:19:29 | 7,093 0 | 7,093 | Form 4 |
| Bailey Megan D. EVP, Pres, Central Labs & Intl | 2024-11-05 08:15:34 | 6,517 0 | 6,517 | Form 4 |
| Davis Jeffrey A. Director | 2024-02-08 12:44:31 | 6,454 0 | 6,454 | Form 4 |
| Uthgenannt Lisa J Chief Human Resources Officer | 2019-09-06 09:54:44 | 5,894 0 | 5,894 | Form 4 |
| Wengel Kathryn E Director | 2024-02-08 12:51:21 | 5,127 0 | 5,127 | Form 4 |
| Schroeder Mark S EVP, Pres Diagnostics & COO | 2024-04-03 08:35:28 | 5,036 0 | 5,036 | Form 4 |
| Summy Amy B. EVP, Chief Marketing Officer | 2024-11-26 11:06:07 | 4,319 0 | 4,319 | Form 4 |
| Seltz Judith C EVP, CHRO | 2023-04-03 10:03:43 | 4,182 0 | 4,182 | Form 4 |
| Kliphouse Kirsten Marie Director | 2024-02-08 12:46:59 | 4,154 0 | 4,154 | Form 4 |
| van der Vaart Sandra D EVP, Chief Legal Officer | 2024-11-25 08:14:59 | 2,670 0 | 2,670 | Form 4 |
| COLES N ANTHONY Director | 2013-02-19 17:48:29 | 2,584 0 | 2,584 | Form 4 |
| Wilkinson Peter J SVP, Chief Accounting Officer | 2024-05-01 18:29:47 | 2,087 0 | 2,087 | Form 4 |
| Oyegunwa Akinbolade EVP, CIO & CTO | 2024-11-05 08:18:42 | 2,082 0 | 2,082 | Form 4 |
| Rothman Paul Director | 2024-06-10 08:52:54 | 1,661 0 | 1,661 | Form 4 |
| Watson Craig M Director | 2005-05-13 12:56:01 | 1,288 0 | 1,288 | Form 4 |